Procollagen I N-Peptide Monoclonal Antibody (C6) | Invitrogen MA5-41662 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

Procollagen I N-Peptide Monoclonal Antibody (C6)

catalog :

MA5-41662

quantity :

200 uL

price :

US 500.00

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

C6

The same clone is also sold as:

MyBioSource: MBS2025685

reactivity :

human

application :

western blot, immunohistochemistry, immunohistochemistry - paraffin section

product information

Product Type :

Antibody

Product Name :

Procollagen I N-Peptide Monoclonal Antibody (C6)

Catalog # :

MA5-41662

Quantity :

200 uL

Price :

US 500.00

Clonality :

Monoclonal

Purity :

Protein A/G

Host :

Mouse

Reactivity :

Human

Applications :

Immunohistochemistry (Paraffin): 5-50 ug/mL, Western Blot: 0.5-5 ug/mL

Species :

Human

Clone :

Isotype :

IgG1, kappa

Storage :

-20 C

Description :

Procollagen type I N-terminal propeptide (P1NP) is a specific marker of bone formation, reflecting the synthesis of type I collagen, which constitutes the major part of the bone matrix. P1NP is derived during the conversion of procollagen to collagen, produced by osteoblasts during bone formation. Its primary clinical application lies in the diagnosis and monitoring of metabolic bone diseases, particularly osteoporosis. In osteoporotic patients, P1NP levels can predict bone mineral density (BMD) responses to treatments like teriparatide and romosozumab. Low serum levels of P1NP are indicative of a high risk of BMD loss, providing a valuable tool for premenopausal women with systemic lupus erythematosus (SLE) and other conditions affecting bone health.

Immunogen :

Recombinant protein Procollagen I N-Terminal Propeptide

Format :

Liquid

Applications w/Dilutions :

Immunohistochemistry (Paraffin): 5-50 ug/mL, Western Blot: 0.5-5 ug/mL

Aliases :

P1NP; Procollagen I N